Prescription drug · ANDA
Dutasteride NDC 84091-100
Dutasteride .5 mg/1 · Capsule · Oral · Banyan Pharma LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84091-100-90 | 84091010090 | 90 CAPSULE in 1 BOTTLE (84091-100-90)Marketed from Dec 31, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dutasteride
- Generic name (nonproprietary)
- dutasteride
- Active ingredients
- Dutasteride — .5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Banyan Pharma LLCNDC labeler code 84091
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204705
- Marketing start
- Listing expires
- Other FDA classes
- 5-alpha Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 84091-100_aff70ad7-652a-496f-b351-58c3ebd446e9SPL ID aff70ad7-652a-496f-b351-58c3ebd446e9SPL set ID 947644ea-bc35-41df-8a7a-874360c90192RxCUI 351172UNII O0J6XJN02I
- Pharmacologic class
- 5-alpha Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484091010090followed by a unit qualifier and the quantityPackage 84091-0100-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dutasteride is a 5 alpha-reductase inhibitor indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: ( 1.1 ) improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of the need for BPH-related surgery. Dutasteride in combination with the alpha adrenergic antagonist, tamsulosin, is indicated for the treatment of symptomatic BPH in men with an enlarged prostate. ( 1.2 ) Limitations of Use: Dutasteride is not approved for the prevention of prostate cancer. ( 1.3 ) 1.1 Monotherapy Dutasteride capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prosta…
Excerpt only. Read the full label for complete information.
About NDC 84091-100
- What is NDC 84091-100?
- 84091-100 is the product NDC for Dutasteride, Dutasteride .5 mg/1 capsule, listed with the FDA by Banyan Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dutasteride.
- What is the active ingredient?
- Dutasteride.
- Who is the labeler?
- Banyan Pharma LLC, NDC labeler code 84091. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dutasteride?
- 20 other product NDCs are listed under this name. See all Dutasteride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dutasteride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | 59651-021 | 59651-0021-3059651-0021-90 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | A-S Medication Solutions | 50090-7305 | 50090-7305-0050090-7305-01 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | XLCare Pharmaceuticals, Inc. | 72865-140 | 72865-0140-3072865-0140-90 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | NuCare Pharmaceuticals, Inc. | 68071-3757 | 68071-3757-06 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | A-S Medication Solutions | 50090-7852 | 50090-7852-0050090-7852-01 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | NuCare Pharmaceuticals, Inc. | 68071-3857 | 68071-3857-09 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Epic Pharma, LLC | 42806-549 | 42806-0549-0942806-0549-30 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | MARKSANS PHARMA LIMITED | 25000-011 | 25000-0011-0325000-0011-0725000-0011-27 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Strides Pharma Science Limited | 64380-763 | 64380-0763-0464380-0763-05 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Camber Pharmaceuticals, Inc. | 31722-131 | 31722-0131-3031722-0131-90 |